(Q33437541)

26 July 2017

1 reference

title

Gender differences in Parkinson's disease (English)

1 reference

26 July 2017

1 reference

Lisa M Shulman

1

1 reference

26 July 2017

1 March 2007

1 reference

26 July 2017

1 reference

26 July 2017

4

1 reference

26 July 2017

1

1 reference

26 July 2017

8-18

1 reference

In vitro dopamine release from the rat striatum: diurnal rhythm and its modification by the estrous cycle.

26 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980003-9

7 January 2021

Striatal D-2 dopamine agonist binding sites fluctuate during the rat estrous cycle

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980003-9

7 January 2021

Direct effect of 17 beta-estradiol on striatum: sex differences in dopamine release

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980003-9

7 January 2021

Effect of chronic estradiol and progesterone treatments of ovariectomized rats on brain dopamine uptake sites.

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980003-9

7 January 2021

Sex differences and effects of estrogen on dopamine and DOPAC release from the striatum of male and female CD-1 mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980003-9

7 January 2021

Sex differences in the amphetamine stimulated release of catecholamines from rat striatal tissue in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980003-9

7 January 2021

In vivo changes in responsiveness of the caudate nucleus to L-dopa infusion as a function of the estrous cycle.

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980003-9

7 January 2021

Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980003-9

7 January 2021

Estrogen alters MPTP-induced neurotoxicity in female mice: effects on striatal dopamine concentrations and release.

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980003-9

7 January 2021

The Impact of Gender and Estrogen on Striatal Dopaminergic Neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980003-9

7 January 2021

Estrogen is essential for maintaining nigrostriatal dopamine neurons in primates: implications for Parkinson's disease and memory.

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980003-9

7 January 2021

Mechanisms of antiapoptotic effects of estrogens in nigral dopaminergic neurons

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980003-9

7 January 2021

Epidemiology of parkinsonism: Incidence, classification, and mortality

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980003-9

7 January 2021

The effect of estrogen replacement on early Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980003-9

7 January 2021

Increased frontal [(18)F]fluorodopa uptake in early Parkinson's disease: sex differences in the prefrontal cortex

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980003-9

7 January 2021

Short-term effects of high-dose 17beta-estradiol in postmenopausal PD patients: a crossover study

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980003-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS1550-8579%2807%2980003-9

1 reference

7 January 2021

10.1016/S1550-8579(07)80003-9

Identifiers

DOI

1 reference

26 July 2017

1 reference

PubMed ID

17584622